Now let me compile the comprehensive reference document for human SNCA.
SNCA (Alpha-Synuclein) - Comprehensive Cross-Database Identifier and Functional Mapping Reference
Gene: SNCA (synuclein alpha)
Species: Homo sapiens (Human)
Last Updated: 2026-03-27
Section 1: Gene Identifiers
Core Gene Identifiers
| Database | Identifier | Notes |
|---|
| HGNC ID | HGNC:11138 | Approved symbol: SNCA |
| HGNC Symbol | SNCA | Approved name: synuclein alpha |
| Ensembl Gene ID | ENSG00000145335 | GRCh38 |
| NCBI Entrez Gene ID | 6622 | |
| OMIM Gene ID | 163890 | Gene/locus |
Genomic Location (GRCh38/hg38)
| Attribute | Value |
|---|
| Chromosome | 4 |
| Cytogenetic Band | 4q22.1 |
| Start Position | 89,700,345 |
| End Position | 89,838,315 |
| Strand | Minus (-) |
| Genomic Accession | NC_000004.12 |
| Gene Span | ~138 kb |
Gene Nomenclature
| Attribute | Values |
|---|
| Previous Symbols | PARK1, PARK4 |
| Aliases | NACP, PD1 |
| Previous Names | Parkinson disease (autosomal dominant, Lewy body) 4; synuclein, alpha (non A4 component of amyloid precursor) |
| Locus Type | protein-coding gene |
| Gene Family | Synuclein family |
Section 2: Transcript Identifiers
Ensembl Transcripts
Total Transcript Count: 32 transcripts
| Transcript ID | Biotype | Start | End | Canonical |
|---|
| ENST00000336904 | protein_coding | 89724099 | 89838315 | Yes (MANE) |
| ENST00000345009 | protein_coding | 89725884 | 89835680 | |
| ENST00000394986 | protein_coding | 89726053 | 89837139 | |
| ENST00000394989 | protein_coding | 89724105 | 89837199 | |
| ENST00000394991 | protein_coding | 89724099 | 89837161 | |
| ENST00000420646 | protein_coding | 89724099 | 89836976 | |
| ENST00000502987 | protein_coding | 89821849 | 89835695 | |
| ENST00000505199 | protein_coding | 89726616 | 89835685 | |
| ENST00000506244 | protein_coding | 89726577 | 89837168 | |
| ENST00000506691 | protein_coding | 89822352 | 89837076 | |
| ENST00000508895 | protein_coding | 89726258 | 89836213 | |
| ENST00000611107 | protein_coding | 89726628 | 89835667 | |
| ENST00000618500 | protein_coding | 89724099 | 89836213 | |
| ENST00000673718 | protein_coding | 89724115 | 89837015 | |
| ENST00000673766 | protein_coding_CDS_not_defined | 89724113 | 89771957 | |
| ENST00000673902 | protein_coding | 89700345 | 89837310 | |
| ENST00000674129 | protein_coding | 89725343 | 89837310 | |
| ENST00000889657 | protein_coding | 89726055 | 89838265 | |
| ENST00000889658 | protein_coding | 89726055 | 89838210 | |
| ENST00000889659 | protein_coding | 89726053 | 89837660 | |
| ENST00000889660 | protein_coding | 89725536 | 89836262 | |
| ENST00000889662 | protein_coding | 89726055 | 89836607 | |
| ENST00000889663 | protein_coding | 89726136 | 89835949 | |
| ENST00000912364 | protein_coding | 89726254 | 89837016 | |
| ENST00000912365 | protein_coding | 89726055 | 89836701 | |
| ENST00000965186 | protein_coding | 89726060 | 89838263 | |
| ENST00000965187 | protein_coding | 89725519 | 89837189 | |
| ENST00000965188 | protein_coding | 89726060 | 89837200 | |
| ENST00000965189 | protein_coding | 89726060 | 89837198 | |
| ENST00000965190 | protein_coding | 89726062 | 89836979 | |
| ENST00000965191 | protein_coding | 89726137 | 89836747 | |
| ENST00000965192 | protein_coding | 89726137 | 89836507 | |
RefSeq Transcripts (Human)
Total RefSeq mRNA Count: 10 reviewed human transcripts
| RefSeq ID | Type | Status | MANE Select |
|---|
| NM_000345 | mRNA | REVIEWED | Yes ✓ |
| NM_001146054 | mRNA | REVIEWED | No |
| NM_001146055 | mRNA | REVIEWED | No |
| NM_001375285 | mRNA | REVIEWED | No |
| NM_001375286 | mRNA | REVIEWED | No |
| NM_001375287 | mRNA | REVIEWED | No |
| NM_001375288 | mRNA | REVIEWED | No |
| NM_001375290 | mRNA | REVIEWED | No |
| NM_007308 | mRNA | REVIEWED | No |
| NR_164674-NR_164676 | ncRNA | REVIEWED | No |
CCDS Identifiers
Canonical Transcript Exons (ENST00000336904)
Total Exon Count: 6 exons
| Exon ID | Start | End | Strand |
|---|
| ENSE00001484185 | 89838252 | 89838315 | - |
| ENSE00001407446 | 89835547 | 89835692 | - |
| ENSE00000970012 | 89828143 | 89828184 | - |
| ENSE00000970013 | 89822246 | 89822388 | - |
| ENSE00000970014 | 89729194 | 89729277 | - |
| ENSE00003902180 | 89724099 | 89726660 | - |
Section 3: Protein Identifiers
UniProt Accessions
Total UniProt Entries: 8
| UniProt ID | Status | Name | Notes |
|---|
| P37840 | Reviewed (Swiss-Prot) | Alpha-synuclein | Canonical ✓ |
| A0A669KB41 | Unreviewed (TrEMBL) | | Isoform |
| A0A669KBH5 | Unreviewed (TrEMBL) | | Isoform |
| D6RA31 | Unreviewed (TrEMBL) | | Isoform |
| E7EPV7 | Unreviewed (TrEMBL) | | Isoform |
| H6UYS0 | Unreviewed (TrEMBL) | | Isoform |
| H6UYS5 | Unreviewed (TrEMBL) | | Isoform |
| H6UYS7 | Unreviewed (TrEMBL) | | Isoform |
Canonical Protein Properties (P37840)
| Property | Value |
|---|
| Protein Name | Alpha-synuclein |
| Alternative Names | Non-A beta component of AD amyloid; Non-A4 component of amyloid precursor |
| Length | 140 amino acids |
| Molecular Mass | 14,460 Da |
RefSeq Protein Accessions
| RefSeq Protein ID | Status | MANE Select |
|---|
| NP_000336 | REVIEWED | Yes ✓ |
| NP_001139526 | REVIEWED | No |
| NP_001139527 | REVIEWED | No |
| NP_001362214 | REVIEWED | No |
| NP_001362215 | REVIEWED | No |
| NP_001362216 | REVIEWED | No |
| NP_001362217 | REVIEWED | No |
| NP_001362219 | REVIEWED | No |
| NP_009292 | REVIEWED | No |
Protein Domains and Families
| Database | ID | Name | Type |
|---|
| InterPro | IPR001058 | Synuclein | Family |
| InterPro | IPR002460 | Synuclein_alpha | Family |
| Pfam | PF01387 | Synuclein | Domain |
Section 4: Structure Identifiers
Experimental Structures (PDB)
Total PDB Structure Count: 208 structures
| PDB ID | Method | Resolution | Title |
|---|
| 1XQ8 | Solution NMR | - | Human micelle-bound alpha-synuclein |
| 2KKW | NMR/EPR | - | SLAS-micelle bound alpha-synuclein |
| 2N0A | Solid-state NMR | - | Atomic-resolution structure of alpha-synuclein fibrils |
| 3Q25 | X-ray | 1.90 Å | Alpha-synuclein (1-19) fused to MBP |
| 3Q26 | X-ray | 1.54 Å | Alpha-synuclein (10-42) fused to MBP |
| 3Q27 | X-ray | 1.30 Å | Alpha-synuclein (32-57) fused to MBP |
| 3Q28 | X-ray | 1.60 Å | Alpha-synuclein (58-79) fused to MBP |
| 6A6B | Cryo-EM | 3.07 Å | Alpha-synuclein fiber |
| 6CU7 | Cryo-EM | 3.50 Å | Alpha-synuclein fibril - Rod Polymorph |
| 6CU8 | Cryo-EM | 3.60 Å | Alpha-synuclein fibril - Twister Polymorph |
| 6H6B | Cryo-EM | 3.40 Å | Alpha-synuclein fibrils |
| 6I42 | X-ray | 1.38 Å | Alpha-synuclein PreNAC/Cyclophilin A complex |
| 6OSJ | Cryo-EM | 2.80 Å | N-terminally acetylated full length alpha-synuclein fibrils |
| 6UFR | Cryo-EM | 2.50 Å | E46K alpha-synuclein fibrils |
| 6XYO | Cryo-EM | 2.60 Å | Multiple system atrophy Type I alpha-synuclein filament |
| 7E0F | Cryo-EM | 3.02 Å | G51D alpha-synuclein amyloid fibril |
| 7LRQ | Cryo-EM | 3.49 Å | A53T alpha-synuclein amyloid fibril |
| 8A9L | Cryo-EM | 2.20 Å | Alpha-synuclein filaments from Parkinson's disease/DLB |
| 8BQV | Cryo-EM | 2.00 Å | Alpha-synuclein from Juvenile-onset synucleinopathy |
| 9EUU | Cryo-EM | 1.93 Å | Recombinant alpha-synuclein fibrils 1B (highest res) |
Structure Methods Summary:
- Cryo-EM: ~150 structures (majority are fibril structures)
- X-ray Diffraction: ~30 structures
- Solution NMR: ~15 structures
- Solid-state NMR: ~5 structures
- Electron Crystallography: ~5 structures
Predicted Structures (AlphaFold)
| AlphaFold ID | Sequence Length | Global pLDDT | Fraction Very High pLDDT |
|---|
| P37840 | 1013 | 74.29 | 0.28 |
Note: Alpha-synuclein is intrinsically disordered, reflected in lower AlphaFold confidence scores
Section 5: Cross-Species Orthologs
Model Organism Orthologs
| Species | Gene ID | Symbol | Genome |
|---|
| Mouse (Mus musculus) | ENSMUSG00000025889 | Snca | mus_musculus |
| Rat (Rattus norvegicus) | ENSRNOG00000008656 | Snca | rattus_norvegicus |
| Zebrafish (Danio rerio) | No direct ortholog | - | - |
| Fruit fly (Drosophila) | No ortholog | - | - |
| C. elegans | No ortholog | - | - |
| Yeast (S. cerevisiae) | No ortholog | - | - |
Note: Synucleins are vertebrate-specific proteins with no orthologs in invertebrate model organisms
Section 6: Clinical Variants & AI Predictions
ClinVar Clinical Variants
Total ClinVar Variant Count: 189 variants
Classification Breakdown:
| Classification | Count |
|---|
| Pathogenic | ~5 |
| Likely pathogenic | ~3 |
| Pathogenic/Likely pathogenic (CNV) | ~3 |
| Uncertain Significance (VUS) | ~45 |
| Likely Benign | ~55 |
| Benign | ~35 |
| Conflicting classifications | ~5 |
TOP 50 Pathogenic/Likely Pathogenic Variants
| ClinVar ID | HGVS Notation | Classification | Condition |
|---|
| 14007 | NM_000345.4:c.157G>A (p.Ala53Thr) | Pathogenic | Parkinson disease |
| 14010 | NM_000345.4:c.136G>A (p.Glu46Lys) | Pathogenic | Parkinson disease |
| 14008 | NM_000345.4:c.88G>C (p.Ala30Pro) | Likely pathogenic | Parkinson disease |
| 1120010 | 4q22.1 copy number gain | Pathogenic | Parkinson disease |
| 1454898 | SNCA duplication | Pathogenic | Parkinson disease |
Note: Most SNCA pathogenic variants are rare missense mutations or copy number gains (duplications/triplications) causing autosomal dominant Parkinson disease
AlphaMissense Variant Effect Predictions
Total Predicted Variants: 898 missense variants scored
Classification Distribution (Sample of 100):
| Classification | Count |
|---|
| Likely Benign | ~85 |
| Ambiguous | ~12 |
| Likely Pathogenic | ~3 |
TOP Predicted Pathogenic Missense Variants:
| Variant | Position | Pathogenicity Score | Classification |
|---|
| A140D | 4:89726632 | 0.807 | Likely pathogenic |
| A140P | 4:89726633 | 0.699 | Likely pathogenic |
Note: Most C-terminal variants are benign; pathogenic variants cluster in NAC domain (residues 61-95)
SpliceAI Splice Effect Predictions
Total SpliceAI Predictions: 1,592 variants
TOP Splice-Altering Variants (delta score >0.5):
| Variant | Effect | Delta Score |
|---|
| 4:89726487:T>TA | Donor gain | 0.90 |
| 4:89726657:CTTC>C | Acceptor gain | 0.87 |
| 4:89726601:T>TG | Acceptor gain | 0.80 |
| 4:89725343:A>T | Acceptor gain | 0.76 |
| 4:89725341:C>T | Acceptor gain | 0.74 |
| 4:89726656:CCTTC>C | Acceptor gain | 0.73 |
| 4:89726528:ACTTT>A | Acceptor gain | 0.68 |
| 4:89725337:A>T | Acceptor gain | 0.65 |
| 4:89725345:A>T | Acceptor gain | 0.64 |
| 4:89726530:T>A | Acceptor gain | 0.62 |
Section 7: Biological Pathways & Gene Ontology
Reactome Pathways
Total Pathway Count: 7 pathways
| Pathway ID | Pathway Name | Disease Pathway |
|---|
| R-HSA-977225 | Amyloid fiber formation | No |
| R-HSA-9833482 | PKR-mediated signaling | No |
| R-HSA-1169410 | Antimicrobial mechanism of IFN-stimulated genes | No |
| R-HSA-1280215 | Cytokine Signaling in Immune system | No |
| R-HSA-168256 | Immune System | No |
| R-HSA-392499 | Metabolism of proteins | No |
| R-HSA-913531 | Interferon Signaling | No |
Gene Ontology Annotations
Total GO Terms: 150
Molecular Function (TOP 20)
| GO ID | Term |
|---|
| GO:0005515 | protein binding |
| GO:0042802 | identical protein binding |
| GO:0008289 | lipid binding |
| GO:0005543 | phospholipid binding |
| GO:0008017 | microtubule binding |
| GO:0003779 | actin binding |
| GO:0000149 | SNARE binding |
| GO:0048156 | tau protein binding |
| GO:0005507 | copper ion binding |
| GO:0005509 | calcium ion binding |
| GO:0008270 | zinc ion binding |
| GO:0008198 | ferrous iron binding |
| GO:0000287 | magnesium ion binding |
| GO:0004857 | enzyme inhibitor activity |
| GO:0004860 | protein kinase inhibitor activity |
| GO:0004869 | cysteine-type endopeptidase inhibitor activity |
| GO:0042393 | histone binding |
| GO:0019894 | kinesin binding |
| GO:0043014 | alpha-tubulin binding |
| GO:0048487 | beta-tubulin binding |
Biological Process (TOP 20)
| GO ID | Term |
|---|
| GO:0007268 | chemical synaptic transmission |
| GO:0016079 | synaptic vesicle exocytosis |
| GO:0016082 | synaptic vesicle priming |
| GO:0007269 | neurotransmitter secretion |
| GO:0042416 | dopamine biosynthetic process |
| GO:0042417 | dopamine metabolic process |
| GO:0001963 | synaptic transmission, dopaminergic |
| GO:0035493 | SNARE complex assembly |
| GO:0048489 | synaptic vesicle transport |
| GO:0048488 | synaptic vesicle endocytosis |
| GO:0043066 | negative regulation of apoptotic process |
| GO:0043065 | positive regulation of apoptotic process |
| GO:0051259 | protein complex oligomerization |
| GO:1990000 | amyloid fibril formation |
| GO:0034599 | cellular response to oxidative stress |
| GO:0007006 | mitochondrial membrane organization |
| GO:0042775 | mitochondrial ATP synthesis coupled electron transport |
| GO:0050808 | synapse organization |
| GO:0014059 | regulation of dopamine secretion |
| GO:0031115 | negative regulation of microtubule polymerization |
Cellular Component (TOP 20)
| GO ID | Term |
|---|
| GO:0005737 | cytoplasm |
| GO:0005829 | cytosol |
| GO:0005886 | plasma membrane |
| GO:0045202 | synapse |
| GO:0098793 | presynapse |
| GO:0008021 | synaptic vesicle |
| GO:0030672 | synaptic vesicle membrane |
| GO:0043195 | terminal bouton |
| GO:0030424 | axon |
| GO:0043679 | axon terminus |
| GO:0043025 | neuronal cell body |
| GO:0005739 | mitochondrion |
| GO:0005743 | mitochondrial inner membrane |
| GO:0005741 | mitochondrial outer membrane |
| GO:0005634 | nucleus |
| GO:0016234 | inclusion body |
| GO:0099512 | supramolecular fiber |
| GO:0005764 | lysosome |
| GO:0030426 | growth cone |
| GO:0005576 | extracellular region |
Section 8: Protein Interactions & Molecular Networks
STRING Protein-Protein Interactions
Total Interaction Count: 4,810+ interactions
TOP 50 Highest-Confidence Interacting Proteins:
| Interactor | UniProt | Confidence Score |
|---|
| SNCA (self) | P37840 | 999 |
| PRKN (Parkin) | O60260 | 999 |
| DJPC1 (DJ-1) | Q9Y6H5 | 998 |
| TARDBP | Q13148 | 995 |
| PARK7 | Q99497 | 986 |
| PRNP (Prion) | P04156 | 984 |
| HTT (Huntingtin) | P42858 | 983 |
| SNCAIP (Synphilin-1) | Q9Y6H5 | 980 |
| TOMM22 | Q15388 | 980 |
| TH (Tyrosine Hydroxylase) | P07101 | 975 |
| LRRK2 | Q5S007 | 973 |
| VDAC1 | P21796 | 972 |
| MAPT (Tau) | P10636 | 971 |
| HSPA4 | P34932 | 970 |
| APOE | P02649 | 967 |
| HSPA8 | P11142 | 962 |
| CALM1 | P02593 | 955 |
| APP | P05067 | 954 |
| PINK1 | Q9BXM7 | 947 |
| UCHL1 | P09936 | 940 |
IntAct Protein Interactions
Total IntAct Interactions: 734+ curated interactions
High-Confidence Interactions (Score ≥0.7):
| Interactor | Type | Confidence |
|---|
| SNCA (homo-oligomer) | direct interaction | 0.99 |
| APOE | physical association | 0.81 |
| SNCAIP | physical association | 0.80 |
| TPPP | direct interaction | 0.72 |
| SERF1A | direct interaction | 0.65 |
| VAMP2 | physical association | 0.63 |
| CLU (Clusterin) | physical association | 0.66 |
| APP | physical association | 0.66 |
| APOA1 | physical association | 0.62 |
Protein Structural/Embedding Similarity (ESM2)
Total Similar Proteins: 51
TOP 20 Structurally Similar Proteins:
| UniProt ID | Top Similarity | Average Similarity |
|---|
| P61138 | 1.000 | 0.983 |
| P61139 | 1.000 | 0.983 |
| P61140 | 1.000 | 0.983 |
| P61141-P61145 | 1.000 | 0.983 |
| B3EWG3 | 1.000 | 0.976 |
| O55042 (Mouse) | 0.9999 | 0.981 |
| P37377 (Beta-syn) | 0.9999 | 0.981 |
| Q16143 (Gamma-syn) | 0.999 | 0.983 |
| P33567 | 0.999 | 0.982 |
| O76070 | 0.9996 | 0.984 |
Protein Sequence Homology (DIAMOND)
Total Homologous Proteins: 17
| UniProt ID | Identity | BitScore |
|---|
| P37840 | 100% | 139 |
| P61138-P61145 | 99-100% | 137-149 |
| O55042 (Mouse Snca) | 99.3% | 158 |
| P37377 (Mouse/Rat) | 99.3% | 158 |
| P61147 | 90.7% | 147 |
| Q16143 (SNCG, Gamma) | 93.3% | 109 |
Section 9: Transcription Factor Regulatory Data
SNCA as Target of TFs (CollecTRI)
Total Upstream Regulators: 21 transcription factors
| TF Gene | Regulation | Confidence |
|---|
| YY1 | Activation | High |
| NR4A2 (NURR1) | Activation | - |
| GATA2 | Unknown | High |
| BATF | - | High |
| IRF9 | - | High |
| ISL1 | - | High |
| NFATC1 | - | High |
| PARP1 | - | High |
| PRDM1 | - | High |
| ZNF219 | - | High |
| CEBPB | Unknown | - |
| ESR1 | - | Low |
| BCL6 | - | Low |
| PAX6 | - | Low |
| NONO | - | Low |
| TBX21 | - | Low |
| ZNF436 | - | Low |
| ZSCAN21 | Unknown | - |
| SRF | - | - |
| VPS35 | Repression | - |
| OPRD1 | Repression | - |
SNCA as Transcription Regulator
| Target Gene | Regulation |
|---|
| CADPS2 | Repression |
Note: Alpha-synuclein is not a classical transcription factor but has been reported to regulate some gene expression
Signaling Interactions (SIGNOR)
Total Signaling Interactions: 27
Key Kinases Phosphorylating SNCA:
| Kinase | Effect | Mechanism | Score |
|---|
| SNCAIP | Up-regulates activity | Binding | 0.80 |
| ROS | Up-regulates quantity | - | 0.70 |
| GRK5 | Down-regulates activity | Phosphorylation | 0.64 |
| LRRK2 | Down-regulates activity | Phosphorylation | 0.62 |
| DYRK1A | Up-regulates | Phosphorylation | 0.56 |
| SYK | Down-regulates | Phosphorylation | 0.53 |
| CSNK2A1 | Down-regulates activity | Phosphorylation | 0.51 |
| PLK2 | Down-regulates activity | Phosphorylation | 0.48 |
| ABL1 | Up-regulates quantity | Phosphorylation | 0.42 |
| CSNK1A1 | Down-regulates activity | Phosphorylation | 0.37 |
Downstream Effects of SNCA:
| Effect | Mechanism |
|---|
| Lewy body formation | Up-regulates |
| ER stress | Up-regulates |
| VAMP2 quantity | Down-regulates (binding) |
| CADPS2 expression | Down-regulates (transcriptional) |
Section 10: Drug & Pharmacology Data
ChEMBL Target Information
| ChEMBL Target ID | Type | Target Name |
|---|
| CHEMBL6152 | Single Protein | Alpha-synuclein |
| CHEMBL5465209 | PPI | Cereblon/Alpha-synuclein |
| CHEMBL5465232 | PPI | VHL/Alpha-synuclein |
| CHEMBL5483090 | PPI | cIAP1/Alpha-synuclein |
Drug Molecules Targeting SNCA
Total Targeting Molecules: 100+ compounds tested
TOP 30 Molecules by Development Phase:
| ChEMBL ID | Name | Type | Highest Phase |
|---|
| CHEMBL135 | ESTRADIOL | Small molecule | Phase 4 (Approved) |
| CHEMBL1405 | ESTRONE | Small molecule | Phase 4 (Approved) |
| CHEMBL1440 | TETRACYCLINE | Small molecule | Phase 4 (Approved) |
| CHEMBL1550 | PHYTONADIONE | Small molecule | Phase 4 (Approved) |
| CHEMBL161 | CEFTRIAXONE | Small molecule | Phase 4 (Approved) |
| CHEMBL1908919 | FLORBETAPIR | Small molecule | Phase 4 (Approved) |
| CHEMBL193482 | ESTRIOL | Small molecule | Phase 4 (Approved) |
| CHEMBL140 | CURCUMIN | Small molecule | Phase 3 |
| CHEMBL259223 | MENATETRENONE | Small molecule | Phase 3 |
| CHEMBL286494 | HYPERICIN | Small molecule | Phase 3 |
| CHEMBL297453 | EGCG | Small molecule | Phase 3 |
| CHEMBL1368322 | PARAROSANILINE | Small molecule | Phase 2 |
| CHEMBL151 | LUTEOLIN | Small molecule | Phase 2 |
| CHEMBL288114 | GALLIC ACID | Small molecule | Phase 2 |
| CHEMBL164 | MYRICETIN | Small molecule | Preclinical |
| CHEMBL125743 | GALLOCATECHIN | Small molecule | Preclinical |
| CHEMBL129451 | CATECHINGALLATE | Small molecule | Preclinical |
| CHEMBL224392 | THIOFLAVIN T | Small molecule | Preclinical |
DrugBank Entries
| DrugBank ID |
|---|
| DB02709 |
| DB04209 |
| DB09130 |
PharmGKB Pharmacogenomics
| PharmGKB ID | Symbol | VIP Status | CPIC Guideline |
|---|
| PA35986 | SNCA | Yes (VIP) | No |
Note: SNCA is designated as a Very Important Pharmacogene (VIP) due to its relevance in Parkinson's disease pharmacogenomics
Section 11: Expression Profiles
Tissue Expression Summary (Bgee)
| Metric | Value |
|---|
| Expression Breadth | Ubiquitous |
| Total Present Calls | 280 |
| Total Absent Calls | 9 |
| Total Conditions | 289 |
| Max Expression Score | 99.43 |
| Average Expression Score | 83.97 |
| Gold Quality Conditions | 257 |
TOP 30 Expressing Tissues
| Rank | Tissue/Structure | Expression Score | Quality |
|---|
| 1 | Trabecular bone tissue | 99.43 | Gold |
| 2 | Orbitofrontal cortex | 99.38 | Gold |
| 3 | Pons | 99.25 | Gold |
| 4 | Brodmann area 46 | 99.09 | Gold |
| 5 | Brodmann area 23 | 98.76 | Gold |
| 6 | Tendon of biceps brachii | 98.74 | Gold |
| 7 | Postcentral gyrus | 98.72 | Gold |
| 8 | Parietal lobe | 98.69 | Gold |
| 9 | Middle temporal gyrus | 98.65 | Gold |
| 10 | Substantia nigra pars compacta | 98.58 | Gold |
| 11 | Superior frontal gyrus | 98.58 | Gold |
| 12 | Brodmann area 9 | 98.58 | Gold |
| 13 | Olfactory bulb | 98.47 | Gold |
| 14 | Entorhinal cortex | 98.30 | Gold |
| 15 | Right frontal lobe | 98.20 | Gold |
| 16 | Cranial nerve II | 98.04 | Gold |
| 17 | Substantia nigra pars reticulata | 98.01 | Gold |
| 18 | Prefrontal cortex | 97.98 | Gold |
| 19 | Amygdala | 97.68 | Gold |
| 20 | Cerebellar hemisphere | 97.65 | Gold |
| 21 | Temporal lobe | 97.63 | Gold |
| 22 | Dorsolateral prefrontal cortex | 97.61 | Gold |
| 23 | Substantia nigra | 97.55 | Gold |
| 24 | Ammon's horn (Hippocampus) | 97.55 | Gold |
| 25 | Cerebellar cortex | 97.52 | Gold |
| 26 | Right cerebellar hemisphere | 97.51 | Gold |
| 27 | Tibial nerve | 97.42 | Gold |
| 28 | C1 cervical spinal cord | 97.35 | Gold |
| 29 | Midbrain | 97.25 | Gold |
| 30 | Blood | 97.15 | Gold |
Cell Type Expression
| Cell Type | Expression Score | Quality |
|---|
| Endothelial cell | 98.76 | Gold |
| Monocyte | 98.59 | Gold |
| Mononuclear cell | 98.25 | Gold |
Single-Cell Expression Datasets (SCXA)
Total Single-Cell Datasets: 22
| Dataset ID | Description | Cell Count |
|---|
| E-CURD-122 | Cross-tissue immune cell analysis | 356,580 |
| E-MTAB-7407 | Human fetal liver, skin, kidney | 473,803 |
| E-HCAD-4 | Census of Immune Cells | 791,344 |
| E-CURD-98 | Human Fetal Liver | 197,943 |
| E-CURD-114 | Human airway epithelium | 81,801 |
| E-CURD-112 | Fetal bone marrow | 56,592 |
| E-HCAD-23 | First-trimester placenta/decidua | 41,132 |
| E-MTAB-9221 | COVID-19 blood | 27,943 |
| E-MTAB-8205 | hPSC endothelial-to-haematopoietic | 25,764 |
| E-HCAD-5 | Organoid inter-individual variation | 25,049 |
Section 12: Disease Associations
Mendelian/Monogenic Disease Links (GenCC)
Total Curated Gene-Disease Associations: 9
| Disease | Disease ID | Inheritance | Classification | Submitter |
|---|
| Parkinson disease | MONDO:0005180 | AD | Definitive | Ambry Genetics |
| AD Parkinson disease 4 | OMIM:605543 | AD | Definitive | Ambry Genetics |
| AD Parkinson disease 1 | OMIM:168601 | AD | Strong | Genomics England |
| AD Parkinson disease 4 | OMIM:605543 | AD | Strong | Genomics England |
| Lewy body dementia | OMIM:127750 | AD | Strong | Genomics England |
| AD Parkinson disease 4 | OMIM:605543 | AD | Strong | Labcorp |
| Lewy body dementia | OMIM:127750 | AD | Strong | Labcorp |
| Hereditary late-onset PD | ORPHA:411602 | AD | Supportive | Orphanet |
| Parkinsonian-pyramidal syndrome | ORPHA:171695 | AR | Supportive | Orphanet |
Orphanet Rare Disease Associations
| Orphanet ID | Disease Name | Type | Gene Count |
|---|
| 171695 | Parkinsonian-pyramidal syndrome | Disease | 2 |
| 2828 | Young-onset Parkinson disease | Disease | 11 |
| 411602 | Hereditary late-onset Parkinson disease | Disease | 7 |
Phenotype Associations (HPO)
Total HPO Phenotype Terms: 81
TOP 50 Associated Clinical Phenotypes:
| HPO ID | Phenotype |
|---|
| HP:0001300 | Parkinsonism |
| HP:0002548 | Parkinsonism with favorable response to dopaminergic medication |
| HP:0002067 | Bradykinesia |
| HP:0002063 | Rigidity |
| HP:0001337 | Tremor |
| HP:0002322 | Resting tremor |
| HP:0002080 | Intention tremor |
| HP:0002172 | Postural instability |
| HP:0001288 | Gait disturbance |
| HP:0002141 | Gait imbalance |
| HP:0002362 | Shuffling gait |
| HP:0002359 | Frequent falls |
| HP:0002304 | Akinesia |
| HP:0002375 | Hypokinesia |
| HP:0001332 | Dystonia |
| HP:0100660 | Dyskinesia |
| HP:0001336 | Myoclonus |
| HP:0000726 | Dementia |
| HP:0001268 | Mental deterioration |
| HP:0100543 | Cognitive impairment |
| HP:0000727 | Frontal lobe dementia |
| HP:0000738 | Hallucinations |
| HP:0002367 | Visual hallucination |
| HP:0000746 | Delusion |
| HP:0011999 | Paranoia |
| HP:0100753 | Schizophrenia |
| HP:0000716 | Depression |
| HP:0000739 | Anxiety |
| HP:0025269 | Panic attack |
| HP:0000741 | Apathy |
| HP:0000713 | Agitation |
| HP:0100710 | Impulsivity |
| HP:0001260 | Dysarthria |
| HP:0031435 | Monotonic speech |
| HP:0031908 | Micrographia |
| HP:0002015 | Dysphagia |
| HP:0001278 | Orthostatic hypotension |
| HP:0004926 | Orthostatic hypotension due to autonomic dysfunction |
| HP:0012332 | Abnormal autonomic nervous system physiology |
| HP:0002019 | Constipation |
| HP:0012450 | Chronic constipation |
| HP:0002578 | Gastroparesis |
| HP:0002360 | Sleep disturbance |
| HP:0100785 | Insomnia |
| HP:0012452 | Restless legs |
| HP:0004409 | Hyposmia |
| HP:0100315 | Lewy bodies |
| HP:0002171 | Gliosis |
| HP:0011960 | Substantia nigra gliosis |
| HP:0002120 | Cerebral cortical atrophy |
GWAS Associations
Total GWAS Associations: 39
TOP 30 GWAS Trait Associations:
| GWAS ID | Trait | P-value | Mapped Gene |
|---|
| GCST004902_48 | Parkinson's disease | 5×10⁻¹²³ | SNCA |
| GCST009325_4 | PD or first-degree relative | 4×10⁻¹⁵⁴ | SNCA |
| GCST009325_94 | PD or first-degree relative | 5×10⁻¹⁴⁹ | SNCA |
| GCST002544_19 | Parkinson's disease | 4×10⁻⁷³ | SNCA |
| GCST001445_5 | Parkinson's disease | 6×10⁻⁶⁵ | SNCA |
| GCST003984_5 | Parkinson's disease | 1×10⁻⁵⁶ | SNCA |
| GCST009325_93 | PD or first-degree relative | 1×10⁻⁴⁸ | SNCA |
| GCST000959_7 | Parkinson's disease | 2×10⁻⁴⁷ | SNCA |
| GCST010049_1 | Parkinson's disease | 2×10⁻³⁷ | SNCA |
| GCST009325_5 | PD or first-degree relative | 1×10⁻³⁶ | SNCA |
| GCST001430_2 | Parkinson's disease | 8×10⁻³⁵ | SNCA |
| GCST003922_2 | Parkinson's disease | 1×10⁻³² | SNCA |
| GCST006585_2238 | Blood protein levels | 8×10⁻³⁰ | SNCA |
| GCST001126_2 | Parkinson's disease | 2×10⁻¹⁹ | SNCA |
| GCST003800_1 | Bupropion response in depression | 3×10⁻⁸ | GPRIN3-SNCA |
| GCST000530_1 | Parkinson's disease | 7×10⁻¹⁷ | SNCA |
| GCST000528_4 | Parkinson's disease | 2×10⁻¹⁶ | SNCA |
| GCST000855_3 | Parkinson's disease | 9×10⁻¹⁶ | SNCA |
| GCST005276_2 | Dementia with Lewy bodies | 9×10⁻¹³ | SNCA |
| GCST007780_1 | PD age of onset | 2×10⁻¹² | SNCA |
| GCST012354_9 | Anxiety | 4×10⁻¹¹ | SNCA |
| GCST000772_1 | Parkinson's disease | 3×10⁻¹¹ | SNCA |
| GCST009373_1 | PD in GBA mutation carriers | 2×10⁻¹¹ | SNCA |
| GCST002353_3 | Parkinson's disease | 3×10⁻¹¹ | SNCA |
| GCST001445_6 | Parkinson's disease | 5×10⁻¹¹ | SNCA-AS1 |
| GCST006940_38 | Neuroticism | 2×10⁻¹⁰ | SNCA |
| GCST006948_44 | Feeling nervous | 1×10⁻⁹ | SNCA |
| GCST006585_643 | Blood protein levels | 1×10⁻⁹ | SNCA |
| GCST002353_2 | Parkinson's disease | 1×10⁻⁹ | SNCA |
| GCST009512_1 | Parkinson's disease | 2×10⁻⁹ | SNCA |
DATA SOURCES
| Section | Primary Databases |
|---|
| Gene IDs | HGNC, Ensembl, NCBI Entrez, OMIM |
| Transcripts | Ensembl, RefSeq, CCDS |
| Proteins | UniProt, RefSeq, InterPro, Pfam |
| Structures | PDB, AlphaFold |
| Orthologs | Ensembl Compara |
| Variants | ClinVar, AlphaMissense, SpliceAI |
| Pathways | Reactome, Gene Ontology |
| Interactions | STRING, IntAct, BioGRID, SIGNOR |
| Regulation | CollecTRI |
| Drugs | ChEMBL, DrugBank, PharmGKB |
| Expression | Bgee, Single Cell Expression Atlas |
| Disease | GenCC, OMIM, Orphanet, HPO, GWAS Catalog |
This reference document provides comprehensive cross-database identifiers and functional annotations for SNCA. Data retrieved via biobtree integration of 70+ biological databases.
I have compiled a comprehensive cross-database identifier and functional mapping reference for human SNCA (alpha-synuclein).
Summary of Key Data:
| Section | Count |
|---|
| Gene Identifiers | HGNC:11138, ENSG00000145335, Entrez 6622, OMIM 163890 |
| Transcripts | 32 Ensembl, 10 RefSeq mRNA (MANE: NM_000345) |
| Proteins | 8 UniProt (Canonical: P37840), 140 aa, 14.5 kDa |
| PDB Structures | 208 experimental structures (mostly Cryo-EM fibrils) |
| ClinVar Variants | 189 (including A53T, E46K, A30P pathogenic mutations) |
| AlphaMissense | 898 scored missense variants |
| SpliceAI | 1,592 splice predictions |
| GO Terms | 150 annotations |
| Reactome Pathways | 7 pathways |
| STRING Interactions | 4,810+ protein interactions |
| IntAct Interactions | 734+ curated interactions |
| Targeting Drugs | 100+ compounds (7 approved drugs) |
| HPO Phenotypes | 81 clinical phenotypes |
| GWAS Associations | 39 (strongest: Parkinson's disease at p=5×10⁻¹²³) |
Clinical Significance: SNCA is definitively linked to autosomal dominant Parkinson's disease (PARK1/PARK4) and dementia with Lewy bodies. It is a PharmGKB Very Important Pharmacogene (VIP) with
extensive structural data on pathological fibril formation.